1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- has been researched along with Edema, Pulmonary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giaid, A; Kuang, JQ; Ohlstein, EH; Shennib, H | 1 |
1 other study(ies) available for 1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- and Edema, Pulmonary
| Article | Year |
|---|---|
Endothelin receptor antagonist improves pulmonary hemodynamics during lung ischemia/reperfusion injury.
Topics: Animals; Blood Pressure; Cold Temperature; Endothelin Receptor Antagonists; Hemodynamics; Indans; Ischemia; Lung Compliance; Oxygen; Partial Pressure; Pulmonary Artery; Pulmonary Circulation; Pulmonary Edema; Rabbits; Reperfusion Injury; Vascular Resistance | 1998 |